ReviewFrontiers in immunology2021

Fit-For-All iPSC-Derived Cell Therapies and Their Evaluation in Humanized Mice With NK Cell Immunity.

Charlotte Flahou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.